How safe is carvedilol in NIDDM patients with hypertension?
Choudhury
D
D
Department of Medicine, All India Institute of Medical Sciences, New Delhi.
Misra
A
A
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D002227:Carbazoles / Q000627:therapeutic use*; D000077261:Carvedilol; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D004311:Double-Blind Method; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D011412:Propanolamines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D000959:Antihypertensive Agents; D001786:Blood Glucose; D002227:Carbazoles; D008055:Lipids; D011412:Propanolamines; D000077261:Carvedilol; D001262:Atenolol